sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Pentanediamide

Pentanediamide

CAS No.:
3424-60-0
Catalog Number:
AG003TM6
Molecular Formula:
C5H10N2O2
Molecular Weight:
130.1451
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
98%
In Stock USA
United States
$100
- +
1g
98%
In Stock USA
United States
$300
- +
5g
98%
In Stock USA
United States
$900
- +
10g
98%
In Stock USA
United States
$1500
- +
Product Description
Catalog Number:
AG003TM6
Chemical Name:
Pentanediamide
CAS Number:
3424-60-0
Molecular Formula:
C5H10N2O2
Molecular Weight:
130.1451
MDL Number:
MFCD00297145
IUPAC Name:
pentanediamide
InChI:
InChI=1S/C5H10N2O2/c6-4(8)2-1-3-5(7)9/h1-3H2,(H2,6,8)(H2,7,9)
InChI Key:
RCCYSVYHULFYHE-UHFFFAOYSA-N
SMILES:
NC(=O)CCCC(=O)N
NSC Number:
24865
Properties
Complexity:
108  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
130.074g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
130.147g/mol
Monoisotopic Mass:
130.074g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
86.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.7  
Literature
Title Journal
Bis(imidate)palladium(II) complexes with labile ligands. Mimics of classical precursors? Dalton transactions (Cambridge, England : 2003) 20111221
Hydrogen-bonding dynamics in aqueous solutions of amides and acids: monomer, dimer, trimer, and polymer. The journal of physical chemistry. B 20081030
Cyclization of the acyl glucuronide metabolite of a neutral endopeptidase inhibitor to an electrophilic glutarimide: synthesis, reactivity, and mechanistic analysis. Journal of medicinal chemistry 20071129
The discovery of small molecule inhibitors of neutral endopeptidase. Structure-activity studies on functionalized glutaramides. Chemical biology & drug design 20060101
Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia. Bioorganic & medicinal chemistry letters 20040906
Properties